The activation of SIRT3 may represent a promising therapeutic strategy to improve mitochondrial function and treat related cardiovascular diseases (Mihanfar et al., 2018; Wu J. et al., 2019). The gene discussed is SIRT3; the disease is cardiovascular disorder.